mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.004 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |